Exosomes in development, metastasis and drug resistance of breast cancer

Cancer Science

Volumn 106, Issue 8, 2015, Pages 959-964

  Yu, Dan dan ^a,b   Wu, Ying ^a,b   Shen, Hong yu ^b   Lv, Meng meng ^a   Chen, Wei xian ^a,b   Zhang, Xiao hui ^b   Zhong, Shan liang ^b   Tang, Jin hai ^b   Zhao, Jian hua ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

Author keywords

Breast cancer; Exosomes; Metastasis; Resistance; Therapeutics

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; NUCLEIC ACID; PROTEIN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER RESISTANCE; CELL COMMUNICATION; CELL MEMBRANE TRANSPORT; EARLY CANCER; EXOSOME; HUMAN; IMMUNOGENICITY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; STROMA CELL; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; BREAST NEOPLASMS; DRUG DELIVERY SYSTEM; DRUG RESISTANCE; FEMALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; EXOSOMES; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 84939253225     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12715     Document Type: Review

References (69)

1. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014; 64: 52-62.
2. Donepudi MS, Kondapalli K, Amos SJ, Venkanteshan P. Breast cancer statistics and markers. J Cancer Res Ther 2014; 10: 506-511.
3. Zhang ZJ, Ma SL. miRNAs in breast cancer tumorigenesis (Review). Oncol Rep 2012; 27: 903-910.
4. Hsu KS, Kao HY. Alpha-actinin 4 and tumorigenesis of breast cancer. Vitam Horm 2013; 93: 323-351.
5. Xia LP, Zhou FF, Yang MT, Liu Q. Roles of Aurora-A in tumorigenesis and prognosis of breast cancer. Ai Zheng 2009; 28: 668-672.
6. Rahim F, Hajizamani S, Mortaz E et al. Molecular regulation of bone marrow metastasis in prostate and breast cancer. Bone Marrow Res 2014; 2014: 405920.
7. Staals RH, Pruijn GJ. The human exosome and disease. Adv Exp Med Biol 2010; 702: 132-142.
8. Kosaka N, Yoshioka Y, Tominaga N, Hagiwara K, Katsuda T, Ochiya T. Dark side of the exosome: the role of the exosome in cancer metastasis and targeting the exosome as a strategy for cancer therapy. Future Oncol 2014; 10: 671-681.
9. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 2000; 113: 3365-3374.
10. Ostrowski M, Carmo NB, Krumeich S et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010; 12: 19-30, 1-13.
11. van den Boorn JG, Daßler J, Coch C, Schlee M, Hartmann G. Exosomes as nucleic acid nanocarriers. Adv Drug Deliv Rev 2013; 65: 331-335.
12. Gonzalez-Begne M, Lu B, Han X et al. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res 2009; 8: 1304-1314.
13. Mathew A, Bell A, Johnstone RM. Hsp-70 is closely associated with the transferrin receptor in exosomes from maturing reticulocytes. Biochem J 1995; 308: 823-830.
14. Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 2006; 66: 4795-4801.
15. Putz U, Howitt J, Doan A et al. The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal 2012; 5: a70.
16. Lim JW, Mathias RA, Kapp EA et al. Restoration of full-length APC protein in SW480 colon cancer cells induces exosome-mediated secretion of DKK-4. Electrophoresis 2012; 33: 1873-1880.
17. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012; 7: e30679.
18. Okumura Y, Nishimura R, Nakatsukasa K et al. Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence. Eur J Surg Oncol 2015; 41: 548-552.
19. Alco G, Bozdogan A, Selamoglu D et al. Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients. Oncol Lett 2015; 9: 1046-1054.
20. Ross JS, Fletcher JA, Linette GP et al. The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 2003; 8: 307-325.
21. Zhang L, Xiao H, Karlan S et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS One 2010; 5: e15573.
22. Zhang L, Farrell JJ, Zhou H et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010; 138: 949-957.
23. Mali SB. Proteomics for oral cancer. Oral Oncol 2014; 50: e67.
24. Lau CS, Wong DT. Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PLoS One 2012; 7: e33037.
25. Lau C, Kim Y, Chia D et al. Role of pancreatic cancer-derived exosomes in salivary biomarker development. J Biol Chem 2013; 288: 26888-26897.
26. Khan S, Bennit HF, Turay D et al. Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer 2014; 14: 176.
27. Al-Hajj M. Cancer stem cells and oncology therapeutics. Curr Opin Oncol 2007; 19: 61-64.
28. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004; 23: 7274-7282.
29. Thompson CA, Purushothaman A, Ramani VC, Vlodavsky I, Sanderson RD. Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J Biol Chem 2013; 288: 10093-10099.
30. King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 2012; 12: 421.
31. Clayton A, Tabi Z. Exosomes and the MICA-NKG2D system in cancer. Blood Cells Mol Dis 2005; 34: 206-213.
32. Jiang H, Li Z, Li X, Xia J. Intercellular transfer of messenger RNAs in multiorgan tumorigenesis by tumor cell-derived exosomes. Mol Med Rep 2015; 11: 4657-4663.
33. Ahmed SF1, Das N1, Sarkar M1, Chatterjee U2, Chatterjee S2, Ghosh MK. Corrigendum to "Exosome-mediated delivery of the intrinsic C-terminus domain of PTEN protects it from proteasomal degradation and ablates tumorigenesis". Mol Ther 2015; 23: 407.
34. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-322.
35. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
36. Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 2010; 18: 884-901.
37. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002; 296: 1046-1049.
38. Polyak K, Kalluri R. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol 2010; 2: a3244.
39. Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013; 32: 623-642.
40. Dutta S, Warshall C, Bandyopadhyay C, Dutta D, Chandran B. Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PLoS One 2014; 9: e97580.
41. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007; 8: 341-352.
42. Higginbotham JN, Demory BM, Gephart JD et al. Amphiregulin exosomes increase cancer cell invasion. Curr Biol 2011; 21: 779-786.
43. Singh R, Pochampally R, Watabe K, Lu Z, Mo YY. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol Cancer 2014; 13: 256.
44. Yang M, Chen J, Su F et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 2011; 10: 117.
45. Suetsugu A, Honma K, Saji S, Moriwaki H, Ochiya T, Hoffman RM. Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv Drug Deliv Rev 2013; 65: 383-390.
46. Cho JA, Park H, Lim EH, Lee KW. Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int J Oncol 2012; 40: 130-138.
47. Vong S, Kalluri R. The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. Genes Cancer 2011; 2: 1139-1145.
48. Luga V, Zhang L, Viloria-Petit AM et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012; 151: 1542-1556.
49. Lin R, Wang S, Zhao RC. Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model. Mol Cell Biochem 2013; 383: 13-20.
50. Zhou W, Fong MY, Min Y et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014; 25: 501-515.
51. Meads MB, Gatenby RA, Dalton WS. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer 2009; 9: 665-674.
52. Lagadec C, Vlashi E, Della DL et al. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res 2010; 12: R13.
53. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 2006; 98: 1777-1785.
54. Tekiner TA, Basaga H. Role of microRNA deregulation in breast cancer cell chemoresistance and stemness. Curr Med Chem 2013; 20: 3358-3369.
55. Kuo MT. Roles of multidrug resistance genes in breast cancer chemoresistance. Adv Exp Med Biol 2007; 608: 23-30.
56. Mao Y, Zhang Y, Qu Q et al. Cancer-associated fibroblasts induce trastuzumab resistance in HER2 positive breast cancer cells. Mol BioSyst 2015; 11: 1029-1040.
57. Boelens MC, Wu TJ, Nabet BY et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell 2014; 159: 499-513.
58. Eldh M, Ekstrom K, Valadi H et al. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One 2010; 5: e15353.
59. Bristow RG, Hill RP. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008; 8: 180-192.
60. Lv MM, Zhu XY, Chen WX et al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumour Biol 2014; 35: 10773-10779.
61. Chen WX, Liu XM, Lv MM et al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One 2014; 9: e95240.
62. Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 2003; 63: 4331-4337.
63. Corcoran C, Rani S, O'Brien K et al. Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One 2012; 7: e50999.
64. Arora A, Scholar EM. Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther 2005; 315: 971-979.
65. Hussain HA, Harvey AJ. Evolution of breast cancer therapeutics: breast tumour kinase's role in breast cancer and hope for breast tumour kinase targeted therapy. World J Clin Oncol 2014; 5: 299-310.
66. Harding CV, Heuser JE, Stahl PD. Exosomes: looking back three decades and into the future. J Cell Biol 2013; 200: 367-371.
67. Tian Y, Li S, Song J et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 2014; 35: 2383-2390.
68. Zhang HG, Kim H, Liu C et al. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim Biophys Acta 2007; 1773: 1116-1123.
69. Wang L, Xie Y, Ahmed KA, et al. Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude mice. Brest Cancer Res TR 2013; 140: 273-284.